← All trials
NCT00384527
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2006
- Primary completion
- Oct 1, 2007
- Completion date
- Oct 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- RomarkLead sponsor
- Wellstar Clinical TrialsOverall official - principal investigator
- Oschner Clinic FoundationOverall official - principal investigator
- Torrence Memorial HospitalOverall official - principal investigator
- Atlanta Institute of Medicine and ResearchOverall official - principal investigator
- Department of Veteran AffairsOverall official - principal investigator
- Winthrop UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.